Cardiol Therapeutics (CRDL) Cash & Equivalents (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Cash & Equivalents came in at $20.2 million in Q1 2026, up 24.31% YoY from $16.2 million in Q1 2025, and up 31.4% on a QoQ basis from $15.4 million in Q4 2025.
Cardiol Therapeutics (CRDL) Cash & Equivalents (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Cash & Equivalents data on file, last reported at $20.2 million in Q1 2026.
- Quarterly Cash & Equivalents rose 24.31% year-over-year to $20.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.2 million (up 24.31% YoY) and the FY2025 annual result came in at $15.4 million, down 29.84% from the prior year.
- Cash & Equivalents rose to $20.2 million in Q1 2026, from $15.4 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $59.1 million in Q1 2022 to a low of $8.4 million in Q3 2025.
- A 5-year average of $28.2 million and a median of $21.9 million in 2024 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 120.75% — and 2024, when it slumped 61.49%.
- Tracing CRDL's Cash & Equivalents over 5 years: stood at $43.8 million in 2022, then slumped by 41.43% to $25.7 million in 2023, then fell by 14.68% to $21.9 million in 2024, then retreated by 29.84% to $15.4 million in 2025, then surged by 31.4% to $20.2 million in 2026.
- The last three Cash & Equivalents figures came in at $20.2 million (Q1 2026), $15.4 million (Q4 2025), and $8.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - | 18.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.18 Mn |
| Dec 31, 2025 | 15.36 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Jun 30, 2025 | 13.13 Mn |
| Mar 31, 2025 | 16.23 Mn |
| Dec 31, 2024 | 21.89 Mn |
| Sep 30, 2024 | 11.64 Mn |
| Jun 30, 2024 | 17.56 Mn |
| Mar 31, 2024 | 21.20 Mn |
| Dec 31, 2023 | 25.66 Mn |
| Sep 30, 2023 | 30.24 Mn |
| Jun 30, 2023 | 33.46 Mn |
| Mar 31, 2023 | 36.59 Mn |
| Dec 31, 2022 | 43.81 Mn |
| Sep 30, 2022 | 50.25 Mn |
| Jun 30, 2022 | 55.26 Mn |
| Mar 31, 2022 | 59.09 Mn |
| Dec 31, 2021 | 66.56 Mn |
| Sep 30, 2021 | 22.76 Mn |
| Jun 30, 2021 | 26.62 Mn |